Serum Angiopoietin-2: A Sensitive Inflammatory Marker in Psoriasis Patients | ||||
| Egyptian Journal of Chemistry | ||||
| Article 6, Volume 64, Issue 11, November 2021, Page 6195-6201 PDF (255.75 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejchem.2021.73608.3636 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Noha M Hammad   1; Tawhed Ismail2; Mahamed Teama2; Hagar Bessar 2
| ||||
| 1Medical Microbiology & Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt | ||||
| 2Dermatology, Venerology and Andrology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt | ||||
| Abstract | ||||
| Psoriasis is an immune-mediated inflammatory skin disease associated with comorbidities. Angiogenesis plays a pivotal role in psoriasis pathogenesis which contributes to the initial events that trigger an autoimmune inflammatory response. Angiopoietins 1 and 2 are glycoproteins. Their binding to the tyrosine kinase receptor is essential to angiogenesis. Dysregulation of angiopoietins together with angiopoietin-2 overexpression induce vascular destabilization and regression. This study aimed to explore the relationship between systemic angiopoietin-2 and psoriasis severity. A total of 45 psoriasis vulgaris patients and 45 matched healthy controls were enrolled in the study. The severity of disease was evaluated by Psoriasis Area and Severity Index. Angiopoietin-2 serum level was measured using enzyme linked-immunosorbent assay. The relation between serum level of angiopoietin-2 and psoriasis severity was assessed. Angiopoietin-2 serum level was significantly more elevated in patients than controls (p < 0.001). Angiopoietin-2 serum level was indicatively direct correlated with disease severity (r = 0.7, p < 0.001) with 100% sensitivity and 90.9% specificity in identifying mild and moderate to severe psoriasis patients. Serum angiopoietin-2 directly correlates with psoriasis severity. Angiopoietin-2 is nominated to be a potential sensitive biomarker for the ongoing inflammatory process to monitor the clinical and therapeutic outcomes in psoriasis patients. | ||||
| Keywords | ||||
| Angiogenesis; angiopoietin-2; inflammatory biomarker; psoriasis | ||||
|
Statistics Article View: 508 PDF Download: 197 |
||||
